Mark Freedman

Dr. Mark Freedman, a neurologist and MS researcher from the University of Ottawa, discusses groundbreaking stem cell therapies for multiple sclerosis. He explains the immune reboot hypothesis, which resets the immune system to examine triggers of MS. Freedman shares surprising durable remission cases where patients did not experience relapse post-treatment. He also highlights the ideal candidates for this therapy and the complexities of integrating stem cell approaches with existing treatments. His insights into MS and the evolving landscape of treatment are both enlightening and hopeful.